V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310007691 | 310008101 | 1.8 | 81.6 | null | 2016-07-27 | 2016-08-21 | ETOPOSIDE | Y | Y | 310019192 | ETOPOSIDE |
| 310007692 | 310008101 | 1.7 | 108.3 | Adjuvant (A) | 2014-08-18 | 2014-08-19 | CISPLATIN + RT | 02 | Y | 310019192 | CISPLATIN + RT |
| 310007693 | 310008101 | null | 68 | Curative (C) | null | 2013-04-21 | Cisplatin | N | N | 310019192 | CISPLATIN |
| 310007694 | 310008101 | 1.64 | 66 | Curative (C) | 2013-12-19 | 2013-12-19 | Rituximab | 2 | N | 310019192 | RITUXIMAB |
| 310007695 | 310008101 | null | 46.25 | null | 2015-11-24 | 2015-12-02 | Etoposide oral | N | N | 310019192 | ETOPOSIDE |
| 310007696 | 310004873 | 1.71 | 96.5 | Not known (9) | 2014-11-09 | 2015-01-20 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 310019214 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007697 | 310004876 | 1.6 | 60.6 | Adjuvant (A) | 2017-10-23 | 2018-03-06 | BEVACIZUMAB + CARBO + PACLITAXEL | N | null | 310019216 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007698 | 310009813 | 1.84 | null | Palliative (P) | 2016-12-11 | 2016-12-20 | Methotrexate intrathecal | N | N | 310019216 | METHOTREXATE INTRATHECAL |
| 310007699 | 310009813 | null | 61.1 | Not known (9) | 2015-01-04 | 2015-05-24 | Etoposide oral | 2 | N | 310019216 | ETOPOSIDE |
| 310007700 | 310004877 | 1.61 | 71.3 | Palliative (P) | 2016-05-29 | 2016-06-04 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310019225 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007701 | 310008104 | 1.49 | 41.4 | null | 2013-08-08 | 2013-08-08 | Docetaxel | Y | null | 310019231 | DOCETAXEL |
| 310007702 | 310004882 | 1.72 | 32.8 | Palliative (P) | 2015-01-28 | 2015-02-27 | Docetaxel | 2 | null | 310019234 | DOCETAXEL |
| 310007703 | 310004883 | 1.78 | 81 | Curative (C) | 2014-02-17 | 2014-09-22 | GDP | 02 | N | 310019236 | GDP |
| 310007704 | 310008105 | 1.57 | null | Palliative (P) | 2014-12-30 | 2015-01-01 | Cisplatin | N | N | 310019247 | CISPLATIN |
| 310007707 | 310004887 | 1.6 | 70.3 | Curative (C) | 2015-12-10 | 2015-12-31 | GDP | 02 | N | 310019261 | GDP |
| 310007708 | 310004888 | 1.43 | 58.4 | Curative (C) | 2015-10-13 | 2015-11-20 | GDP | null | null | 310019263 | GDP |
| 310007709 | 310004888 | 1.7 | 85.3 | Palliative (P) | 2017-07-22 | 2017-08-11 | ALL UKALL2011 Maintenance A1 | N | null | 310019263 | UKALL2011 |
| 310007710 | 310004889 | null | 72.4 | Not known (9) | 2018-05-04 | 2018-05-09 | Bexarotene | N | N | 310019266 | BEXAROTENE |
| 310007711 | 310004890 | 0 | 67.7 | Palliative (P) | 2012-12-27 | 2013-05-13 | CARBOPLATIN + ETOPOSIDE | N | N | 310019267 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310007712 | 310008107 | 1.8 | 73 | Palliative (P) | 2015-04-27 | 2015-05-03 | GDP | 02 | N | 310019274 | GDP |
| 310007713 | 310004891 | 1.81 | 78.9 | Curative (C) | 2016-04-01 | 2016-04-07 | Bexarotene | 02 | N | 310019275 | UKALL2011 |
| 310007714 | 310008108 | 1.59 | 52.7 | null | 2015-09-19 | 2015-09-21 | Cisplatin | 2 | N | 310019275 | CISPLATIN |
| 310007715 | 310004892 | 1.74 | null | Curative (C) | 2017-09-23 | 2017-09-23 | Cisplatin | N | Y | 310019285 | CISPLATIN |
| 310007716 | 310004893 | 1.85 | 68.3 | null | 2017-10-06 | 2017-11-01 | Rituximab | 02 | N | 310019287 | RITUXIMAB |
| 310007717 | 310004894 | 1.6 | null | Adjuvant (A) | 2014-02-01 | 2014-02-27 | ALL UKALL2011 IndB Std Dex (PegAsp) | null | null | 310019289 | ESHAP |
| 310007718 | 310004895 | 1.89 | 93.5 | Curative (C) | 2016-09-01 | 2016-09-03 | GDP | 01 | N | 310019289 | GDP |
| 310007722 | 310010744 | 1.61 | null | Curative (C) | 2015-09-09 | 2015-09-09 | GDP | N | Y | 310019331 | GDP |
| 310007723 | 310004899 | 1.75 | null | Curative (C) | 2017-11-06 | 2017-12-03 | Cisplatin 100 + RT(H&N) 1 day | null | Y | 310019331 | CISPLATIN + RT |
| 310007724 | 310004900 | null | 56.4 | Curative (C) | null | 2015-07-30 | Cyclophosphamide High Dose | 02 | N | 310019334 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007725 | 310004903 | 1.88 | 77.1 | Curative (C) | 2013-08-01 | 2013-08-05 | Cisplatin | N | N | 310019339 | CISPLATIN |
| 310007726 | 310004903 | 1.82 | 0 | Curative (C) | 2015-06-25 | 2015-06-25 | Bevacizumab + CARBOPLATIN + PACLITAXEL | N | Y | 310019339 | BEXAROTENE |
| 310007727 | 310004904 | null | null | null | 2016-11-06 | 2016-11-09 | Rituximab | null | N | 310019349 | RITUXIMAB |
| 310007728 | 310009819 | 1.69 | 103 | Palliative (P) | 2016-07-08 | 2016-07-14 | Cisplatin 7 day | N | N | 310019352 | CISPLATIN |
| 310007729 | 310004905 | 1.7 | 57 | Adjuvant (A) | 2017-01-17 | 2017-01-24 | DOCETAXEL + GEMCITABINE | N | N | 310019357 | DOCETAXEL + GEMCITABINE |
| 310007730 | 310004906 | 1.68 | 61 | Palliative (P) | 2015-07-09 | 2015-09-02 | Rituximab | N | null | 310019357 | RITUXIMAB |
| 310007731 | 310008117 | 1.52 | 62 | Curative (C) | 2016-10-26 | 2016-10-26 | GDP | N | N | 310019360 | GDP |
| 310007732 | 310008118 | null | 94 | Palliative (P) | 2015-09-05 | 2015-09-13 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310019366 | DOCETAXEL + GEMCITABINE |
| 310007733 | 310004910 | 1.49 | 73.1 | null | 2017-05-20 | 2017-09-10 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | N | N | 310019366 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310007734 | 310004911 | 1.81 | 89.55 | Palliative (P) | 2013-08-26 | 2013-09-01 | Ipilimumab | 2 | N | 310019371 | IPILIMUMAB |
| 310007735 | 310011890 | 1.49 | null | Curative (C) | 2014-05-06 | 2014-12-09 | Cisplatin 100 + RT(H&N) 1 day | N | N | 310019372 | CISPLATIN + RT |
| 310007736 | 310004913 | 1.76 | 0 | Palliative (P) | 2016-09-21 | 2016-10-18 | Cyclophosphamide oral | 02 | N | 310019376 | CYCLOPHOSPHAMIDE |
| 310007737 | 310004915 | null | 77.5 | Palliative (P) | 2013-10-31 | 2013-11-12 | ETOPOSIDE | 2 | N | 310019380 | ETOPOSIDE |
| 310007738 | 310004916 | 1.66 | null | Palliative (P) | null | 2013-07-25 | CYCLOPHOSPHAMIDE + ETOPOSIDE + Procarbazine | Y | null | 310019380 | DOCETAXEL + GEMCITABINE |
| 310007739 | 310004917 | 1.6 | 49 | Disease modification (D) | 2016-02-03 | 2016-03-24 | Methotrexate intrathecal | 2 | Y | 310019384 | METHOTREXATE INTRATHECAL |
| 310007740 | 310004918 | 1.65 | 57.4 | Curative (C) | 2016-03-10 | 2016-03-12 | Cyclophosphamide High Dose | 02 | null | 310019388 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310007741 | 310008127 | 1.61 | 71.3 | Palliative (P) | 2014-11-18 | 2014-12-05 | Bevacizumab+Carbo+Pacliaxel | N | N | 310019389 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310007742 | 310004922 | 1.6 | 61 | Curative (C) | 2016-09-12 | 2016-09-15 | CHOP R - 21 days | N | N | 310019394 | CHOP R |
| 310007743 | 310004923 | 1.83 | 84 | Curative (C) | 2016-05-05 | 2016-09-06 | Methotrexate intrathecal | N | N | 310019399 | METHOTREXATE INTRATHECAL |
| 310007744 | 310004923 | 1.59 | 57.6 | Disease modification (D) | 2014-06-19 | 2014-08-04 | Etoposide PBSCT Mobilisat (1.6g/m2) | N | null | 310019399 | ETOPOSIDE |
| 310007745 | 310004924 | 1.7 | null | null | 2016-05-01 | 2016-05-16 | Methotrexate intrathecal | N | N | 310019415 | METHOTREXATE INTRATHECAL |